Search alternatives:
significant decrease » significant increase (Expand Search), significantly increased (Expand Search)
greater decrease » greatest decrease (Expand Search), greater increase (Expand Search), greater disease (Expand Search)
fid decreased » _ decreased (Expand Search), gy decreased (Expand Search), b1 decreased (Expand Search)
significant decrease » significant increase (Expand Search), significantly increased (Expand Search)
greater decrease » greatest decrease (Expand Search), greater increase (Expand Search), greater disease (Expand Search)
fid decreased » _ decreased (Expand Search), gy decreased (Expand Search), b1 decreased (Expand Search)
-
2081
-
2082
-
2083
-
2084
Trends in full immunization coverage among two-year-olds in Sierra Leone, 2008-2019.
Published 2025Subjects: -
2085
Inequalities in full immunization coverage among two-year-olds in Sierra Leone, 2008-2019.
Published 2025Subjects: -
2086
Trends in full immunization coverage among two-year-olds in Sierra Leone, 2008-2019.
Published 2025Subjects: -
2087
-
2088
Receiver operating characteristic curve for anti-NIE antibodies for <i>S. stercoralis.</i>
Published 2025“…The seroprevalence did not significantly decrease following DA treatment. These results include all individuals sampled, irrespective of whether they took the medications. …”
-
2089
NIE ELISA results.
Published 2025“…Twelve months post-MDA, hookworm prevalence decreased to 56.5% in DA- and 34.4% in IDA-treated villages, respectively (<i>p</i><0.001, both comparisons). …”
-
2090
Kato Katz and PCR database 12 months collection.
Published 2025“…Twelve months post-MDA, hookworm prevalence decreased to 56.5% in DA- and 34.4% in IDA-treated villages, respectively (<i>p</i><0.001, both comparisons). …”
-
2091
Master database baseline, 4 weeks and 1 year.
Published 2025“…Twelve months post-MDA, hookworm prevalence decreased to 56.5% in DA- and 34.4% in IDA-treated villages, respectively (<i>p</i><0.001, both comparisons). …”
-
2092
-
2093
-
2094
-
2095
-
2096
Composition of the gut microbiota at the genus level following the administration of MP.
Published 2025Subjects: -
2097
-
2098
-
2099
-
2100
Activity of xylanase in mixed feed and liver (mg saccharide/g sample/h), n = 12/treatment.
Published 2024Subjects: